Blueprint Genetics, NICER Consortium Developing Genetic Test for Immunologic, Hematologic Disorders

Apr 20, 2020

|

NEW YORK – Blueprint Genetics and the North American Immuno-Hematology Clinical Education and Research (NICER) Consortium announced Monday a collaboration on a diagnostic test for patients with immunologic and hematologic disorders.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Blueprint Genetics, NICER Consortium Developing Genetic Test for Immunologic, Hematologic Disorders

To read the full story....

Breaking News

Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test

Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization

ASU Team Wins $6M in Government Funding to Develop Rapid Saliva Testing System for Coronavirus

Biovica Files FDA 510(k) Submission for Breast Cancer Treatment Response Assay

Genetron, CStone Launch Clinical Trial to Develop CDx for Cancer Drug Avapritinib

Natera Cancer Liquid Biopsy Test Coverage to Expand Under New Draft LCD

Featured White Papers

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

What's Popular?

BARDA Awards $5.4M to Luminex for Expanded Respiratory Panel With Coronavirus Target

Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test

Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization

United Airlines Launches COVID-19 Testing Program for Travelers to Hawaii

Natera Cancer Liquid Biopsy Test Coverage to Expand Under New Draft LCD

Sponsorships